0001757610-19-000002.txt : 20190520
0001757610-19-000002.hdr.sgml : 20190520
20190520141424
ACCESSION NUMBER: 0001757610-19-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190520
DATE AS OF CHANGE: 20190520
EFFECTIVENESS DATE: 20190520
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zyus Life Sciences Inc.
CENTRAL INDEX KEY: 0001757610
IRS NUMBER: 000000000
STATE OF INCORPORATION: A9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-339938
FILM NUMBER: 19838320
BUSINESS ADDRESS:
STREET 1: 407 DOWNEY RD
STREET 2: SUITE 204
CITY: SASKATOON
STATE: A9
ZIP: SLN4L8
BUSINESS PHONE: 306-651-7711
MAIL ADDRESS:
STREET 1: 407 DOWNEY RD
STREET 2: SUITE 204
CITY: SASKATOON
STATE: A9
ZIP: SLN4L8
FORMER COMPANY:
FORMER CONFORMED NAME: CB3 Life Sciences Ltd.
DATE OF NAME CHANGE: 20181030
D
1
primary_doc.xml
X0708
D
LIVE
0001757610
Zyus Life Sciences Inc.
204-407 DOWNEY RD
SUITE 204
SASKATOON
A9
SASKATCHEWAN, CANADA
S7N4L8
306-242-2357
SASKATCHEWAN, CANADA
CB3 Life Sciences Ltd.
Corporation
true
2018
Brent
Zettl
204-407 DOWNEY RD
SUITE 204
SASKATOON
A9
SASKATCHEWAN, CANADA
S7N4L8
Executive Officer
Director
President, CEO, Secretary
Adam
Darbellay
204-407 DOWNEY RD
SUITE 204
SASKATOON
A9
SASKATCHEWAN, CANADA
S7N4L8
Executive Officer
CFO
Keith
Carpenter
204-407 DOWNEY RD
SUITE 204
SASKATOON
A9
SASKATCHEWAN, CANADA
S7N4L8
Executive Officer
EVP, Strategy and M&A
Other Health Care
Decline to Disclose
- 06b
false
2019-05-03
false
true
false
37125
18562500
2366788
16195712
Original dollar amounts for offering were in CAD and were converted for this Form D filing to USD using a current conversion rate of 1 USD = 1.3468 CAD. The total amount sold is reflective of the amount sold in the United States.
false
8
0
0
0
false
Zyus Life Sciences Inc.
Brent Zettl
Brent Zettl
President
2019-05-20